127 results
Page 2 of 7
6-K
EX-99.1
guu2tqqrlnu1ezi
2 Jan 24
XORTX Welcomes New Member to the Board of Directors
8:12am
6-K
EX-99.1
4ho1btv
30 Nov 23
XORTX Announces US ATM Offering
4:04pm
6-K
EX-99.1
dwmjc
30 Nov 23
XORTX Announces US ATM Offering
7:30am
424B5
q8qo 7bhocja8frg
29 Nov 23
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.1
gn2trrd
29 Nov 23
Current report (foreign)
7:00am
6-K
EX-99.2
bxidoqrf0z
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
6-K
EX-99.1
bwtmv140hi2n0b8 1lb
13 Nov 23
Current report (foreign)
7:00am
6-K
EX-99.1
y8k wgq8mbx7b3ws
8 Nov 23
XORTX Announces Share Consolidation
5:00pm
6-K
EX-99.1
8jr 4kng9eeoe2i
2 Nov 23
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023
7:00am
6-K
EX-99.1
vagy53d36bb lst7wdx
27 Oct 23
XORTX Announces Results of Special Meeting of Shareholders
6:05pm
6-K
EX-99.1
ectph
25 Oct 23
XORTX Announces Date for Rescheduled Special Meeting of Shareholders
5:00pm
6-K
EX-99.1
kn5pz mofr
25 Oct 23
XORTX Announces Rescheduling of Special Meeting of Shareholders
7:00am
6-K
EX-99.1
qmpd1o5e
12 Oct 23
XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution
7:41am
6-K
EX-99.1
mvdz6
4 Oct 23
XORTX Calls Special Meeting of Shareholders
1:11pm
6-K
EX-99.1
jgdpiu
28 Sep 23
XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023
7:56am
6-K
EX-99.1
4ub86ec1nvnu4
12 Sep 23
XORTX Announces Participation at Upcoming Investor Conferences
3:56pm
6-K
EX-99.1
zr9fb644
7 Sep 23
XORTX Joins the Kidney Foundation and Kidney March
8:23am
6-K
EX-99.1
9pasad5mbhq3d8vuv
29 Aug 23
XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease
7:00am
424B3
uwnqkiu14i
25 Aug 23
Prospectus supplement
6:00am
424B3
24vg9
25 Aug 23
Prospectus supplement
6:00am